Literature DB >> 17516225

Attraction of phagocytes by apoptotic cells is mediated by lysophosphatidylcholine.

Ruediger B Mueller1, Ahmed Sheriff, Udo S Gaipl, Sebastian Wesselborg, Kirsten Lauber.   

Abstract

Apoptotic cells promote the phagocytosis of themselves via the exposure of "eat me" signals. Furthermore, a second, "find me" signal is required to attract phagocytes. In this review the double function of lysophosphatidylcholine for the clearance of apoptotic material as factor leading to attraction of phagocytes as a soluble "find me" signal and opsonisation of apoptotic cells as a membrane bound "eat me" signal is outlined. Lysophosphatidylcholine, exerting this bivalent function, leads to a sufficient clearance of apoptotic cell as a "keep calm" mechanism to prevent activation of the immune system by secondary necrosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17516225     DOI: 10.1080/08916930701356911

Source DB:  PubMed          Journal:  Autoimmunity        ISSN: 0891-6934            Impact factor:   2.815


  19 in total

1.  Relationship between membrane permeability and specificity of human secretory phospholipase A(2) isoforms during cell death.

Authors:  Jennifer Nelson; Elizabeth Gibbons; Katalyn R Pickett; Michael Streeter; Ashley O Warcup; Celestine H-Y Yeung; Allan M Judd; John D Bell
Journal:  Biochim Biophys Acta       Date:  2011-04-12

2.  Investigation into the role of phosphatidylserine in modifying the susceptibility of human lymphocytes to secretory phospholipase A(2) using cells deficient in the expression of scramblase.

Authors:  Jennifer Nelson; Lyndee L Francom; Lynn Anderson; Kelly Damm; Ryan Baker; Joseph Chen; Sarah Franklin; Amy Hamaker; Izadora Izidoro; Eric Moss; Mikayla Orton; Evan Stevens; Celestine Yeung; Allan M Judd; John D Bell
Journal:  Biochim Biophys Acta       Date:  2012-01-13

Review 3.  The Sound of Silence: Signaling by Apoptotic Cells.

Authors:  Caitlin E Fogarty; Andreas Bergmann
Journal:  Curr Top Dev Biol       Date:  2015-09-11       Impact factor: 4.897

4.  Blood sphingolipidomics in healthy humans: impact of sample collection methodology.

Authors:  Samar M Hammad; Jason S Pierce; Farzan Soodavar; Kent J Smith; Mohammed M Al Gadban; Barbara Rembiesa; Richard L Klein; Yusuf A Hannun; Jacek Bielawski; Alicja Bielawska
Journal:  J Lipid Res       Date:  2010-07-21       Impact factor: 5.922

5.  Acinar ATP8b1/LPC pathway promotes macrophage efferocytosis and clearance of inflammation during chronic pancreatitis development.

Authors:  Wang-Jun Yang; Rong-Chang Cao; Wang Xiao; Xiao-Lou Zhang; Hao Xu; Meng Wang; Zhi-Tao Zhou; Huo-Ji Chen; Jia Xu; Xue-Mei Chen; Jun-Ling Zeng; Shu-Ji Li; Min Luo; Yan-Jiang Han; Xiao-Bing Yang; Guo-Dong Feng; Yu-Heng Lu; Yuan-Yuan Ni; Chan-Gui Wu; Jun-Jie Bai; Zi-Qi Yuan; Jin Jin; Guo-Wei Zhang
Journal:  Cell Death Dis       Date:  2022-10-22       Impact factor: 9.685

Review 6.  Biological Function and Immunotherapy Utilizing Phosphatidylserine-based Nanoparticles.

Authors:  Fiona Y Glassman; Robert Dingman; Helena C Yau; Sathy V Balu-Iyer
Journal:  Immunol Invest       Date:  2020-03-23       Impact factor: 3.657

Review 7.  Efferocytosis in health and disease.

Authors:  Amanda C Doran; Arif Yurdagul; Ira Tabas
Journal:  Nat Rev Immunol       Date:  2019-12-10       Impact factor: 53.106

8.  A mechanism for suppression of the CDP-choline pathway during apoptosis.

Authors:  Craig C Morton; Adam J Aitchison; Karsten Gehrig; Neale D Ridgway
Journal:  J Lipid Res       Date:  2013-10-17       Impact factor: 5.922

9.  Metabolomic basis for response to high dose vitamin D in critical illness.

Authors:  Karin Amrein; Jessica A Lasky-Su; Harald Dobnig; Kenneth B Christopher
Journal:  Clin Nutr       Date:  2020-09-28       Impact factor: 7.324

10.  Apoptosis induction and tumor cell repopulation: the yin and yang of radiotherapy.

Authors:  Kirsten Lauber; Luis E Munoz; Christian Berens; Verena Jendrossek; Claus Belka; Martin Herrmann
Journal:  Radiat Oncol       Date:  2011-12-19       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.